Elimination of cervical cancer by refined vaccination and screening

Matti Lehtinen(Karolinska Institutet), Joakim Dillner(Karolinska University Hospital), Simopekka Vänskä(Finnish Institute for Health and Welfare), Miriam Elfström(Karolinska University Hospital)

International Journal of Cancer

October 25, 2024

10.1002/ijc.35228

Cited by 3

Related Papers

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

|BMJ|2008|630

Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses

|Vaccine|2006|545

A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types

|Virology|2013|317

Epigenome-based cancer risk prediction: rationale, opportunities and challenges

|Nature Reviews Clinical Oncology|2018|173

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

|BMJ|2014|140